Globe Life falls 8.1% after mixed third-quarter results

What happened

Globe Life (GL) fell 8.1% on October 23, 2026, after mixed third-quarter results that missed consensus EPS. The company reported net income of $361 million, or $4.62 per share, a 2% decline from $4.73 per share a year earlier. Its net operating income edged up 1% to $379 million, or $4.84 per share, from $4.81 per share in the prior-year quarter, according to Seeking Alpha and MarketBeat. Trading volume ran 3.3 times its 20-day average as investors digested the report; the S&P 500 fell 0.5% on the day.

How big was the move

The stock fell 8.1% on the session, a move equal to 5.5 times a typical daily move for this stock. That loss was 7.9 percentage points worse than the Financial Services sector median on the day. Over the last five sessions the stock fell 8.3%, while the S&P 500 over five sessions fell 0.5%. Globe Life has a beta of 0.46, so the stock tends to move less than the market; the size of this decline pointed to company-specific news as the likely driver.

The technical picture

On the charts the stock traded below several short- and medium-term averages. It was 6.8% below its 20-day moving average and 9.0% below its 50-day moving average, while it sat 2.8% below its 200-day moving average. The 50-day average remained above the 200-day average, a sign of an established uptrend, but momentum had weakened; the Relative Strength Index (14 days) stood at 26, below 30, a level often called oversold. Over one month the stock fell 7.5% and over three months it fell 11.2%. Over one year the stock rose 14.1%, 0.3 percentage points ahead of the S&P 500. The stock was 19.2% below its 52-week high and showed 23% annualized volatility over 60 days, higher than 52% of its own readings over five years.

Fundamentals and valuation

For the four quarters through September 30, 2026, Globe Life reported revenue of $6.28 billion, up 5.7% from a year earlier and slightly ahead of the 5.3% growth reported one quarter earlier. Diluted earnings per share for the period were $15.01, with earnings per share having risen 8.9% from a year earlier. Margins, however, deteriorated markedly: gross margin declined to 21.2% from 33.8% a year earlier, and operating margin fell to 9.1% from 23.9% a year earlier. Return on invested capital was 1.5%, and the company reduced its share count by 4.6% over one year.

Investors will weigh that margin compression and a modest return on invested capital against the stock's valuation. The stock traded at 10.3 times trailing earnings and 9.8 times expected earnings. Its price to trailing earnings was lower than 67% of its own readings over the past five years, where the five-year median is 12.2 times earnings. PromtFinance scores placed the company solidly in value at 78 (Positive) but showed weak to very weak readings on Growth (23), Quality (26), Revisions (22), Momentum (35) and Stability (30). Globe Life had a market value of $12.97 billion, which investors will consider in light of both the valuation and weakening profitability metrics.

Earnings and analyst expectations

Globe Life reported its last quarterly results on October 21, 2026, with earnings per share of $4.84 versus $4.90 expected, 1.2% below estimates. The company had no consecutive quarters beating estimates, and its average surprise over the last four reports was 1.4% below estimates. Typical two-day reactions after recent reports were modest, with the stock rising 0.3% on average.

Analysts provided a consensus price target of $187.00, which was 20.8% above the closing price on October 23, 2026. Twenty-eight analysts covered the stock; 36% rated it Buy or Strong Buy and the consensus rating was Hold. The next report was scheduled for October 28, 2026.

What to watch

• October 28, 2026: next scheduled earnings report date
• Consensus price target of $187.00, 20.8% above the closing price
• Recent quarter: EPS of $4.84 versus $4.90 expected, 1.2% below estimates
• Trading volume on October 23, 2026: 3.3 times its 20-day average